BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17149650)

  • 41. Australian public hospitals face only a residual role in elective surgery.
    Zinn C
    BMJ; 2003 Jul; 327(7405):12. PubMed ID: 12842945
    [No Abstract]   [Full Text] [Related]  

  • 42. A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.
    Ragupathy R; Aaltonen K; Tordoff J; Norris P; Reith D
    Pharmacoeconomics; 2012 Nov; 30(11):1051-65. PubMed ID: 22963187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?
    Bonastre J; Chevalier J; Van der Laan C; Delibes M; De Pouvourville G
    Health Policy; 2014 Jun; 116(2-3):162-9. PubMed ID: 24314625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dear Minister, please save yourself from activity-based funding.
    Stoelwinder JU
    Med J Aust; 2014 Mar; 200(4):200. PubMed ID: 24580513
    [No Abstract]   [Full Text] [Related]  

  • 45. Financial issues in health. Part 1. Medicare Mark III.
    Frainey M
    Aust Med Rec J; 1993 Jun; 23(2):50-1. PubMed ID: 10130181
    [No Abstract]   [Full Text] [Related]  

  • 46. Economic development and the health care system in Hong Kong.
    Chu DK
    Health Policy; 1994 Jun; 28(3):211-34. PubMed ID: 10135878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Private sector participation in delivering tertiary health care: a dichotomy of access and affordability across two Indian states.
    Katyal A; Singh PV; Bergkvist S; Samarth A; Rao M
    Health Policy Plan; 2015 Mar; 30 Suppl 1(Suppl 1):i23-31. PubMed ID: 25759452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Setting priorities for high-cost medications in public hospitals in Australia: should the public be involved?
    Gallego G; Taylor SJ; Brien JA
    Aust Health Rev; 2011 May; 35(2):191-6. PubMed ID: 21612733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand.
    Raftery JP
    Med J Aust; 2008 Jan; 188(1):26-8. PubMed ID: 18205559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Funding. It's the drug that I want.
    Read C
    Health Serv J; 2013 Feb; 123(6341):S10-2. PubMed ID: 23593917
    [No Abstract]   [Full Text] [Related]  

  • 51. Private medical services in acute-care hospitals in Israel.
    Shirom A
    Int J Health Plann Manage; 2001; 16(4):325-45. PubMed ID: 11771151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 2003-2008 Australian Health Care Agreements: an opportunity for reform.
    Duckett SJ
    Aust Health Rev; 2002; 25(6):24-6. PubMed ID: 12536858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Casemix funding of hospitals: objectives and objections.
    Palmer G
    Health Care Anal; 1996 Aug; 4(3):185-93. PubMed ID: 10162141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [DRGs in psychiatric hospital financing exemplified by Hungary. A model for Germany?].
    Maylath E
    Gesundheitswesen; 2000 Dec; 62(12):633-45. PubMed ID: 11199199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HMO penetration: has it hurt public hospitals?
    Clement JP; Grazier KL
    J Health Care Finance; 2001; 28(1):25-38. PubMed ID: 11669291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Moral hazard and adverse selection in Australian private hospitals: 1989-1990.
    Savage E; Wright DJ
    J Health Econ; 2003 May; 22(3):331-59. PubMed ID: 12683956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The choice of poor patients.
    Pandya S
    Natl Med J India; 2004; 17(2):104-5. PubMed ID: 15141607
    [No Abstract]   [Full Text] [Related]  

  • 58. A roadmap to parity in mental health financing: the case of Lebanon.
    Yehia F; Nahas Z; Saleh S
    J Ment Health Policy Econ; 2014 Sep; 17(3):131-41. PubMed ID: 25543116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reserve capacity of public and private hospitals in response to demand uncertainty.
    Rodriguez-Alvarez A; Roibás D; Wall A
    Health Econ; 2012 Jul; 21(7):839-51. PubMed ID: 21661076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in Medicare disproportionate share (DSH) distribution in US hospitals: 1996-2003.
    Saleh SS; Callan M
    J Health Care Finance; 2006; 33(2):70-83. PubMed ID: 19175241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.